ReviewInternational journal of molecular sciences2025

Navigating Treatment Sequencing in Advanced HR+/HER2- Breast Cancer After CDK4/6 Inhibitors: Biomarker-Driven Strategies and Emerging Therapies.

Dana P Narvaez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.